What is the recommended dosage and duration of Vimovo (naproxen 220 mg/esomeprazole 20 mg) for an adult patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Vimovo Dosage and Duration

For adults and adolescents ≥12 years weighing >50 kg, administer one Vimovo tablet (either 375 mg/20 mg or 500 mg/20 mg naproxen/esomeprazole) twice daily, taken whole with liquid at least 30 minutes before meals, using the lowest effective naproxen dose for the shortest duration consistent with treatment goals. 1

Specific Dosing by Weight and Age

Adults and adolescents ≥12 years weighing >50 kg:

  • One tablet twice daily of either:
    • 375 mg naproxen/20 mg esomeprazole, OR
    • 500 mg naproxen/20 mg esomeprazole 1

Adolescents 12-17 years weighing 38 kg to <50 kg:

  • One tablet of 375 mg naproxen/20 mg esomeprazole twice daily only 1

Administration Requirements

  • Swallow tablets whole—do not crush, chew, or split
  • Take with liquid at least 30 minutes before meals 1
  • The delayed absorption profile makes Vimovo unsuitable for acute pain requiring rapid onset 1

Duration Considerations

Controlled studies do not extend beyond 6 months 1. Use the shortest duration consistent with individual treatment goals, as NSAIDs carry time-dependent cardiovascular and gastrointestinal risks that increase with prolonged use 2, 1. The FDA boxed warning emphasizes that cardiovascular thrombotic risk may occur early in treatment and increases with duration 1.

Special Population Adjustments

Renal impairment:

  • Avoid in moderate to severe renal impairment 1

Hepatic impairment:

  • Avoid in severe hepatic impairment
  • Consider dose reduction in mild to moderate hepatic impairment 1

Critical Contraindications and Warnings

Do not use if:

  • History of asthma, urticaria, or allergic reactions to aspirin or NSAIDs
  • Setting of CABG surgery
  • Taking rilpivirine-containing products
  • Known hypersensitivity to naproxen, esomeprazole, or substituted benzimidazoles 1

Do not substitute Vimovo with separate naproxen and esomeprazole products, as the fixed-dose combination is specifically formulated for sequential delivery with immediate-release esomeprazole followed by enteric-coated naproxen 1.

Minimum Esomeprazole Threshold

If a total daily dose of less than 40 mg esomeprazole is more appropriate for gastric protection, consider a different treatment approach 1. The 20 mg twice-daily dosing (40 mg total daily) was selected as the minimum effective dose for adequate gastric acid suppression 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.